Dr. Mary Flaten Shaya M.D.

Recommended Articles

• Breakthrough Research on Facioscapulohumeral Muscular Dystrophy

  A study which was recently published in the Natural Communications journal, outlines a major breakthrough in research around facioscapulohumeral muscular dystrophy, also known as FSHD.The study was performed by the University of Minnesota Medical School. Researchers at the university inserted the...

• Nortis Inc. Receives $688K to Revolutionize Multiple Sclerosis Treatment

  One Seattle-based technology recently revealed new clinical technology that could completely change the way multiple sclerosis is treated. The firm received $668,000 to develop an in-vitro blood barrier that mimics the human blood-brain barrier, an innovation that would make MS drug development more...

• Stay Updated on Muscular Dystrophy News

  Muscular dystrophy is a critical condition that must be treated immediately to lessen the severity of its symptoms. Though the condition is rare, it's still crucial to become aware of the illness and the recent studies that have been done for you to become more knowledgeable about what you can do to...

• To Tell the Truth...Are Parkinson's Patients Capable of Lying?

  Up until a few years ago, it was believed that those with Parkinson's disease, were only severely limited in their physical capabilities. Parkinson’s is a neurodegenerative disease that is characterized by the progressive destruction of the brain cells located in the person’s substantia nigra....

• Parkinson's Caregivers: More Common for Men than Women?

  As Parkinson's disease slowly progresses into a crippling condition that can incapacitate the patient, many require external aid to perform basic tasks like cooking, cleaning after themselves, getting dressed or even getting around.For these reasons, most patients afflicted with Parkinson’s will...

• Lemtrada Gains FDA Approval to Treat Multiple Sclerosis

  In the United States alone, over 400,000 individuals are dealing with the challenges associated with multiple sclerosis (MS). Most recently, Sanofi, an international leader in healthcare, announced FDA approval of the prescription drug Lemtrada, for the treatment of patients with relapsing forms of...